1 |
Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R. Treatment of toxic epidermal necrolysis. Arch Dermatol 1987;123:1156-8
DOI
ScienceOn
|
2 |
Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, et al. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 2000;57:249-58
DOI
ScienceOn
|
3 |
Mukasa Y, Craven N. Management of toxic epidermal necrolysis and related syndromes. Postgrad Med J 2008;84:60-5
DOI
ScienceOn
|
4 |
Lauerma AI, Reitamo S, Maibach HI. Systemic hydrocortisone/cortisol induces allergic skin reactions in presensitized subjects. J Am Acad Dermatol 1991;24:182-5
DOI
ScienceOn
|
5 |
Schieveld JN, Lousberg R, Berghmans E, Smeets I, Leroy PL, Vos GD, et al. Pediatric illness severity measures predict delirium in a pediatric intensive care unit. Crit Care Med 2008;36:1933-6
DOI
ScienceOn
|
6 |
Kim DW, Jung DE, Koo JW. Steroid and enalapril therapypossible cause of toxic epidermal necrolysis. Korean J Pediatr 2006;49:332-6
DOI
|
7 |
Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience. Arch Dermatol 2003;139:39-43
DOI
ScienceOn
|
8 |
Hergner S, Bilge I, Yavuz YA, Tüzün DU. Steroid-induced psychosis in an adolescent: treatment and prophylaxis with risperidone. Turk J Pediatr 2006;48:244-7
PUBMED
|
9 |
Benyamin R, Vallejo R, Kramer J, Rafeyan R. Corticosteroid induced psychosis in the pain management setting. Pain Physician 2008;11:917-20
PUBMED
ScienceOn
|
10 |
Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, et al. Treatment of toxic epidermal necrolysis with highdose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003;139:26-32
DOI
ScienceOn
|
11 |
Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85
DOI
ScienceOn
|
12 |
Clark LD, Bauer W, Cobb S. Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. N Engl J Med 1952;246:205-16
DOI
PUBMED
ScienceOn
|
13 |
Soliday E, Grey S, Lande MB. Behavioral effects of corticosteroids in steroid-sensitive nephrotic syndrome. Pediatrics. 1999;104:e51
DOI
PUBMED
ScienceOn
|
14 |
Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7
DOI
ScienceOn
|
15 |
Schieveld JN, Leroy PL, van Os J, Nicolai J, Vos GD, Leentjens AF. Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit. Intensive Care Med 2007;33:1033-40
DOI
ScienceOn
|
16 |
Werhli P, Viard I, Bullani R, Tschopp J, French LE. Death receptors in cutaneous in cutaneous biology and disease. J Invest Dermatol 2000;115:141-8
DOI
PUBMED
ScienceOn
|
17 |
Kamanabroo D, Schmitz-Landgraf W, Czarnetzki BM. Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Arch Dermatol 1985;121:1548-9
DOI
ScienceOn
|
18 |
Chave TA, Mortimer NJ, Sladden MJ, Hall AP, Hutchinson PE. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005;153:241-53
DOI
ScienceOn
|
19 |
Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y, et al. Corticosteroid -induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 2001;42:461-6
DOI
ScienceOn
|
20 |
Lopez-Medrano F, Cervera R, Trejo O, Font J, Ingelmo M. Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level. Ann Rheum Dis 2002;61:562-3
DOI
ScienceOn
|